{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:50:58Z","timestamp":1791996658268,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005703","name":"Akdeniz \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ymthe.2020.10.025","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T23:47:03Z","timestamp":1604101623000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes"],"prefix":"10.1016","volume":"29","author":[{"given":"Fulya","family":"Erendor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus Emre","family":"Eksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Ozgecan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Kemal","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-5678","authenticated-orcid":false,"given":"Salih","family":"Sanlioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.10.025_bib1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/db06-0880","article-title":"The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?","volume":"56","author":"Pietropaolo","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2020.10.025_bib2","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41588-019-0524-6","article-title":"The impact of proinflammatory cytokines on the \u03b2-cell regulatory landscape provides insights into the genetics of type 1 diabetes","volume":"51","author":"Ramos-Rodr\u00edguez","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2020.10.025_bib3","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc11-1723","article-title":"Diabetes care for emerging adults","volume":"34","author":"Peters","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2020.10.025_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2020.10.025_bib5","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI130310","article-title":"Insulin: still a miracle after all these years","volume":"129","author":"Barbetti","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.10.025_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1463-1326.2007.00756.x","article-title":"Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies","volume":"9","author":"Heise","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ymthe.2020.10.025_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1464-5491.2006.01913.x","article-title":"Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart","volume":"23","author":"Ashwell","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib8","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJM200504283521721","article-title":"Insulin analogues","volume":"352","author":"Mohn","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/pgmj.2008.067926","article-title":"New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes","volume":"85","author":"Crasto","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ymthe.2020.10.025_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/isl.24590","article-title":"Clinical utility of insulin and insulin analogs","volume":"5","author":"Sanlioglu","year":"2013","journal-title":"Islets"},{"key":"10.1016\/j.ymthe.2020.10.025_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s13300-019-00749-1","article-title":"Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300\u00a0U\/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study","volume":"11","author":"Mathieu","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2337\/db11-1423","article-title":"The clinical potential of C-peptide replacement in type 1 diabetes","volume":"61","author":"Wahren","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2020.10.025_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc12-1211","article-title":"C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study","volume":"36","author":"Marx","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2020.10.025_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1900\/RDS.2009.6.187","article-title":"The beneficial effects of C-Peptide on diabetic polyneuropathy","volume":"6","author":"Kamiya","year":"2009","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.ymthe.2020.10.025_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00125-007-0853-3","article-title":"Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter","volume":"51","author":"Meyer","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib16","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/erm.2012.12","article-title":"Insulin gene therapy from design to beta cell generation","volume":"14","author":"Sanlioglu","year":"2012","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.molmed.2003.08.003","article-title":"In\u00a0vivo gene therapy for diabetes mellitus","volume":"9","author":"Chan","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1042\/bj2790899","article-title":"Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells","volume":"279","author":"Tiedge","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2020.10.025_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0168-8227(01)00220-0","article-title":"Hepatic insulin expression improves glycemic control in type 1 diabetic rats","volume":"52","author":"Dong","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ymthe.2020.10.025_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0092-8674(83)90187-3","article-title":"Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation","volume":"35","author":"Moore","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.10.025_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1043-2760(01)00491-X","article-title":"Hepatic insulin production for type 1 diabetes","volume":"12","author":"Dong","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2020.10.025_bib22","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.3748\/wjg.14.4209","article-title":"Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene","volume":"14","author":"Niu","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib23","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1126\/science.290.5498.1959","article-title":"Glucose-dependent insulin release from genetically engineered K cells","volume":"290","author":"Cheung","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.10.025_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1043-2760(01)00400-3","article-title":"K cells: a novel target for insulin gene therapy for the prevention of diabetes","volume":"12","author":"Corbett","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2020.10.025_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/dmrr.2501","article-title":"Incretins: their physiology and application in the treatment of diabetes mellitus","volume":"30","author":"Tasyurek","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ymthe.2020.10.025_bib26","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2014.7","article-title":"GLP-1-mediated gene therapy approaches for diabetes treatment","volume":"16","author":"Tasyurek","year":"2014","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib27","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/JME-12-0156","article-title":"Therapeutic potential of VIP vs PACAP in diabetes","volume":"49","author":"Sanlioglu","year":"2012","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib28","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","article-title":"Gene therapy and type 1 diabetes mellitus","volume":"108","author":"Chellappan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2020.10.025_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/self.1.3.12643","article-title":"Gene therapy in diabetes","volume":"1","author":"Wong","year":"2010","journal-title":"Self Nonself"},{"key":"10.1016\/j.ymthe.2020.10.025_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/diseases6020042","article-title":"Viral Vectors in Gene Therapy","volume":"6","author":"Lundstrom","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.ymthe.2020.10.025_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune Responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/hgtb.2017.096","article-title":"A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies","volume":"28","author":"White","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2020.10.025_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.omtm.2019.11.004","article-title":"Dosing and Re-Administration of Lentiviral Vector for In\u00a0Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice","volume":"16","author":"Carbonaro-Sarracino","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2020.10.025_bib35","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s00125-007-0722-0","article-title":"Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy","volume":"50","author":"Ren","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1389201017666151223124031","article-title":"Beta Cell Formation in\u00a0vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult Mice","volume":"17","author":"Doiron","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/hum.2017.180","article-title":"Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes","volume":"29","author":"Tasyurek","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41434-018-0011-1","article-title":"HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes","volume":"25","author":"Tasyurek","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00125-008-0931-1","article-title":"Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver","volume":"51","author":"Elsner","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mt.2012.8","article-title":"Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction","volume":"20","author":"Elsner","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/7651_2018_150","article-title":"High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy","volume":"1879","author":"Olgun","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/7651_2018_154","article-title":"High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications","volume":"1879","author":"Olgun","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib43","first-page":"151","article-title":"Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance","volume":"45","author":"Temelkova-Kurktschiev","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib44","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/diacare.22.12.1971","article-title":"Body mass index, diabetes, and C-reactive protein among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2020.10.025_bib45","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.2337\/diacare.21.10.1736","article-title":"Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents","volume":"21","author":"Dom\u00ednguez","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2020.10.025_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aah6192","article-title":"Lentiviral vectors, two decades later","volume":"353","author":"Naldini","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.10.025_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/104303404772680010","article-title":"Transduction of human islets with pseudotyped lentiviral vectors","volume":"15","author":"Kobinger","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib48","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.10.025_bib49","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.gt.3301587","article-title":"A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors","volume":"8","author":"Zhang","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib50","doi-asserted-by":"crossref","first-page":"21223","DOI":"10.1016\/S0021-9258(17)31951-8","article-title":"Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic beta cells. Evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in\u00a0vivo","volume":"269","author":"Kato","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.10.025_bib51","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00007890-200212270-00024","article-title":"Glucose-regulated insulin production in hepatocytes","volume":"74","author":"Alam","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2020.10.025_bib52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mt.2010.255","article-title":"Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter","volume":"19","author":"Han","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib53","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.gt.3300677","article-title":"Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin","volume":"5","author":"Lu","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.10.025_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ijms21010065","article-title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","volume":"21","author":"Mart\u00ednez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2020.10.025_bib55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1196\/annals.1317.041","article-title":"Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice","volume":"1070","author":"Herrera","year":"2006","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ymthe.2020.10.025_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1196\/annals.1317.073","article-title":"VIP and tolerance induction in autoimmunity","volume":"1070","author":"Rosignoli","year":"2006","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ymthe.2020.10.025_bib57","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2337\/diacare.27.11.2769","article-title":"Elevated C-reactive protein levels do not correspond to autoimmunity in type 1 diabetes","volume":"27","author":"Treszl","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ymthe.2020.10.025_bib58","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00125-001-0766-5","article-title":"The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm","volume":"45","author":"Dandona","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymthe.2020.10.025_bib59","first-page":"4189813","article-title":"The Role of Oxidative Stress in the Development of Diabetes Mellitus and Its Complications","volume":"2019","author":"Dos Santos","year":"2019","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.ymthe.2020.10.025_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.biopha.2004.09.011","article-title":"Aspects of oxidative stress in children with type 1 diabetes mellitus","volume":"58","author":"Varvarovsk\u00e1","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2020.10.025_bib61","doi-asserted-by":"crossref","first-page":"e0161548","DOI":"10.1371\/journal.pone.0161548","article-title":"Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects","volume":"11","author":"Fatima","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.10.025_bib62","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1464-5491.2004.01417.x","article-title":"Oxidative stress and glucose levels in a population-based sample","volume":"21","author":"Menon","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib63","first-page":"3415","article-title":"Sphingosine-1-phosphate induces islet \u03b2-cell proliferation and decreases cell apoptosis in high-fat diet\/streptozotocin diabetic mice","volume":"18","author":"He","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ymthe.2020.10.025_bib64","doi-asserted-by":"crossref","first-page":"e13021","DOI":"10.1111\/eci.13021","article-title":"Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth","volume":"48","author":"Malik","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.10.025_bib65","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jcp.27164","article-title":"A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J.\u00a0Cell. Physiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620305967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620305967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:30:12Z","timestamp":1791995412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620305967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1525001620305967"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}